Purchase Order 75F40119P10331
Award Date 8/12/19
Potential Completion Date 12/1/22
Potential Value $164K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...
- This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
- This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...
- The Food and Drug Administration awarded a $242,600 firm fixed-price purchase order to Axion Biosystems, Inc. for an Axion Biosystem Maestro/Microelectrode Array System. The contract was awarded on June 8, 2022, with an ultimate completion date of June 7, 2026, and no small business set-aside was utilized. Performance of the contract is located in Atlanta, Georgia, where Axion Biosystems maintains its headquarters. Axion Biosystems specializes in advanced live cell analysis technologies,...
- The Department of Health and Human Services Food and Drug Administration awarded a $317,900 firm fixed price purchase order to Axion Biosystems, Inc. for the delivery of one Axion Biosystem Maestro Multi-Well Microelectrode Array system. The system will meet the technical requirements outlined in the FDA's February 2023 special notice, including integrated signal amplification, digitization and stimulation hardware, environmental controls, automated plate docking, stimulus design capabilities,...
- This is a $110,200.00 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency within the U.S. Department of Health and Human Services. The contract is for a service and maintenance agreement for an Axion Biosystems instrument, which is likely one of the company's proprietary Maestro multi-electrode array (MEA) systems or related cell analysis platforms. Axion Biosystems, Inc. is the prime contractor, and the contract...
- This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $12,960.00, is for the delivery of CYTOVIEW MEA 48-WELL WHITE PLATE (BOX OF 5) by the prime contractor, Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and instruments. The contract does not have a set-aside designation and has an ultimate...
- This is a $23,690.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced laboratory equipment based in Atlanta, Georgia. The contract is for the procurement of laboratory supplies and consumables to support the FDA's Center for Drug Evaluation and Research (CDER). This award is a small business set-aside and is not associated with a larger contract vehicle. Axion Biosystems has a history...
- This is a $216,245 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for a Multiwell Microelectrode Array System, which is a specialized laboratory instrument used for real-time monitoring of neural and cardiac activity. The prime contractor is Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of biomedical research equipment. This contract...